Amway India launches range of new products under Nutrilite Ayurveda

In a decisive move aligned with India’s nation-building priorities and the Viksit Bharat 2047 vision, Amway India, a leading health and wellbeing company, announced a landmark strategic push into Ayurveda with the launch of Nutrilite Ayurveda.

Driven by the growing consumer demand for plant-based, preventive healthcare, and supported by Government of India’s sustained focus on strengthening the Ayush ecosystem, the company unveiled nine new Ayurveda innovations under the portfolio and aims to build Nutrilite Ayurveda into an Rs. 100 crore category over the next two years. Developed using ayurvedic botanicals responsibly sourced from organically cultivated, NutriCert-certified farms, these products are manufactured at Amway’s state-of-the-art facility in Tamil Nadu.

The launch represents more than an expansion of Amway India’s wellness portfolio. It is an opportunity to contribute to the broader economic value chain around Ayurveda in India – from responsibly sourced botanicals and local agriculture to manufacturing, scientific research, innovation and employment. Bringing together more than 90 years of Nutrilite’s botanical science expertise with a decade of local manufacturing capabilities, Amway India is combining the time-tested wisdom of Ayurveda with modern scientific validation creating a wellness proposition that is Made in India, for India, with the potential to take India’s traditional wellness to the world.

The first phase of roll-out will introduce three Ayurveda formulations — Kalamegha, formulated to support healthy liver function; Shigru (moringa), which helps reduce extra fat deposition and inflammation; and Vrikshamla (garcinia), aimed at improving metabolism and satiety.

Speaking to the media at the launch, Rajneesh Chopra, managing director, Amway India, said, “India is witnessing a significant transformation in traditional wellness, driven by the Government of India’s visionary focus on strengthening the Ayush ecosystem and advancing Ayurveda as an integral part of the country’s health and wellbeing landscape is creating a robust foundation for Ayurveda to thrive in India and gain greater relevance on the global stage. Reflecting our confidence in the immense potential of Ayurveda, we aim to build Nutrilite Ayurveda into a Rs. 100 crore category over the next two years.”

“Today’s consumers are increasingly embracing Ayurveda as an everyday choice for wellness, but they also seek the transparency, consistency and scientific validation they expect from modern wellness products. At Nutrilite, we believe trust is at the heart of what we offer. For Nutrilite Ayurveda, ‘Every Herb Has a Story. We Make Sure It’s True’ is more than a promise. It reflects our commitment to ensuring the quality and traceability of every botanical we offer to consumers so they can embrace Ayurveda with greater confidence,” he added.

  • Related Posts

    Apollo Navi Mumbai launches geriatric oncology clinic

    With a dedicated Geriatric Oncology Clinic, Apollo Hospitals Navi Mumbai brings specialised geriatric cancer care to the private healthcare setting in Navi Mumbai. With the launch of the Geriatric Oncology…

    Maharashtra FDA cancels licences of 62 pharma units, 141 chemist shops

    Mumbai: The Food and Drug Administration (FDA) has cracked down on medical stores violating drug-sale rules, suspending 599 licences and cancelling another 141 after inspecting 2,295 retail establishments across the…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Apollo Navi Mumbai launches geriatric oncology clinic

    Apollo Navi Mumbai launches geriatric oncology clinic

    Maharashtra FDA cancels licences of 62 pharma units, 141 chemist shops

    Maharashtra FDA cancels licences of 62 pharma units, 141 chemist shops

    Himachal DCA honoured with ‘Regulatory Excellence Award’ at iPHEX 2026

    Himachal DCA honoured with ‘Regulatory Excellence Award’ at iPHEX 2026

    Baddi pharma firm loses licence after 1,200-kg tapentadol haul

    Baddi pharma firm loses licence after 1,200-kg tapentadol haul

    US FDA takes steps to maintain newborn access to life-saving starter nutrition products

    US FDA takes steps to maintain newborn access to life-saving starter nutrition products

    Mankind Pharma launches campaign to inspire 1 crore Indians to pledge for organ donation